Tag: devices

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

  • Neftaly Innovations in Glucose Monitoring Devices

    Neftaly Innovations in Glucose Monitoring Devices

    1. Next-Generation Continuous Glucose Monitors (CGMs)

    ✅ Over-the-Counter CGMs

    • FDA in 2024 cleared the first OTC CGM (e.g., Dexcom Stelo), enabling individuals with type 2 diabetes—and even non-diabetics—to gain real-time insights into glucose trends. These devices connect with smartphones and wearables, making metabolic health more accessible .

    ⏳ Longer-Lasting & Implantable Sensors

    • Dexcom G7 15‑Day: FDA‑cleared in 2025, extending wear time for improved convenience .
    • Senseonics Eversense 365: A subcutaneous implant capable of lasting up to one year, promising exceptional longevity and reduced skin irritation .

    2. Non-Invasive & Minimally Invasive Technologies

    ???? Magnetohydrodynamic (MHD) Devices

    • GlucoModicum (Finland): Uses skin‑surface MHD tech to draw interstitial fluid non-invasively for continuous monitoring. Still in development but promising comfort and compliance .

    ???? Optical & Sweat-Based Sensing

    • Plasmonic nanowatch: Integrates silver-coated nanowires and surface plasmon resonance to detect glucose in sweat—demonstrated sensitivity around 0.12 mM .
    • Black phosphorus–graphitic carbon nitride patch: Electrochemical, NFC-enabled skin patch for sweat glucose tracking .

    ???? Breath and Vocal Biomarker Techniques

    • BOYDSense: Measures volatile organic compounds in breath as a proxy for glucose, currently in trials .
    • Voice signal analysis: Experimental ML models predict glucose from vocal biomarkers—an innovative, no-contact approach .

    3. Smart Integration & Analytics

    ???? AI-Powered Predictive Tools

    • CGMs are evolving with AI that advises users on future glucose dips or spikes, integrating seamlessly with smartphones and wearables .
    • Oura Ring now features AI-enabled glucose insights using Stelo CGM data, offering “time above range” metrics and meal-linked analytics .

    ???? Closed‑Loop “Artificial Pancreas” Systems

    • Hybrid closed-loop platforms (e.g., Medtronic MiniMed 670G, Tandem t:slim Control-IQ) automatically adjust insulin delivery based on real-time CGM trends .
    • Open-source tools like OpenAPS empower DIY automated insulin delivery systems, enhancing patient agency .

    4. Multi-Analyte & Holistic Monitoring

    • Future CGMs aim to monitor beyond glucose—tracking ketones, hydration, cortisol, and other metabolic markers for comprehensive health insights .

    5. Wearability & User Experience

    • Devices are becoming ultra-miniaturized, comfortable, and user-friendly—like slim patches, implanted sensors, and wearable tech integrated with familiar formats (watches, rings) .
    • Smart insulin microneedle patches, which both sense glucose and deliver insulin, are in development—bridging sensing with therapy .

    ???? Summary Comparison

    InnovationAdvantageStatus
    OTC/Extended-Wear CGMsGreater accessibility, convenienceAvailable & expanding
    Implantables (e.g., Eversense)Long-term wear without frequent changesFDA-cleared
    Non-invasive sensing (MHD, optical, breath, voice)Pain-free monitoring without piercingsPrototype/early trials
    AI & predictive analyticsTimely alerts and data-driven managementIn use and evolving
    Closed-loop systemsAutomated insulin dosingIn clinical practice
    Multi-analyte sensorsHolistic metabolic monitoringIn development

    ✅ Key Takeaways for Neftaly

    1. Champion cutting-edge CGM devices that offer enhanced access, comfort, and smarter integration.
    2. Develop educational materials explaining emerging non-invasive tech and its potential benefits.
    3. Encourage partnerships using AI-driven apps and wearables to foster proactive glucose management.
    4. Support innovations like AI alerts and closed-loop systems for improved metabolic control and reduced care burden.
    5. Prioritize patient acceptance by promoting wearability and minimal invasiveness.
  • Neftaly Monitoring performance of point-of-care devices

    Neftaly Monitoring performance of point-of-care devices

    Neftaly: Monitoring Performance of Point-of-Care Devices

    Point-of-care (POC) testing devices bring rapid diagnostic capabilities to the bedside, clinic, or field—but speed must never come at the cost of accuracy. At Neftaly, we help organizations monitor and manage the performance of point-of-care devices to ensure reliability, regulatory compliance, and quality patient care.


    Why Monitoring POC Devices Is Essential

    POC devices are often used in decentralized settings by non-laboratory staff, increasing the risk of variability and error. Without continuous performance monitoring, results may be inaccurate or inconsistent—compromising clinical decisions, compliance, and patient safety.


    Neftaly’s Approach to POC Device Performance Monitoring

    1. Verification Before Use

    We support initial verification testing to confirm that each device performs according to the manufacturer’s claims and meets the accuracy requirements for its intended use.

    • Comparison with laboratory reference methods
    • Testing across relevant concentration ranges
    • Operator training and proficiency evaluation

    2. Routine Quality Control (QC)

    Neftaly helps establish robust QC protocols to detect errors before they affect patient results.

    • Daily/shift-based internal QC using control materials
    • Monitoring for drift, bias, or out-of-range results
    • Alerts and documentation for QC failures

    3. External Quality Assessment (EQA/PT)

    We facilitate participation in proficiency testing (PT) or external quality assessment (EQA) programs, where device results are compared to peer labs or reference values.

    • Identification of systemic errors or performance trends
    • Documentation for regulatory bodies and audits
    • Continuous improvement actions based on EQA feedback

    4. Data Review and Trend Analysis

    Using tools like Levey-Jennings charts, mean plots, and control limits, Neftaly enables your team to track performance over time and catch subtle issues before they escalate.

    • Monthly reviews of QC and EQA data
    • Root cause analysis of anomalies
    • Action plans for corrective and preventive measures (CAPA)

    5. Training and Competency

    We ensure that all POC operators are trained, assessed, and documented as competent to use the devices according to SOPs and regulatory expectations.

    • Initial and annual operator assessments
    • Refresher training and protocol updates
    • Audit-ready competency records

    Benefits of Monitoring POC Devices with Neftaly

    • Improved reliability of rapid testing results
    • Fewer diagnostic errors and better patient outcomes
    • Ongoing compliance with ISO 22870, CLIA, and CAP standards
    • Preparedness for regulatory inspections or audits
    • Reduced downtime and device-related costs

    Neftaly’s POC Support Services

    • POC program setup and validation
    • QC and EQA program design and management
    • Customized training for clinical and non-lab personnel
    • Performance audits and continuous improvement consulting
    • SOP development for POC testing workflows

    Fast results should still be the right results.
    With Neftaly, you can trust your point-of-care testing devices to deliver accuracy, consistency, and confidence—every time.

    Need help building or improving your POC testing program? Contact SayPro today!